A $65 million settlement has been reached and is pending approval in the class action lawsuit filed on behalf of consumers who alleged they paid inflated prices for Paxil, a popular anti-depressant drug. The suit alleged that the company filed a series of "sham" patent lawsuits in a campaign to delay any generic version of Paxil from reaching the market. (Feb-03-05) [LAW.COM] [EMAIL LAW FIRM]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in our form on the right to submit your complaint.

Add Your Comment on This Issue

Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Request Legal Help